Skip to Main Content
Winner of a 2022 DIANA from HDA!
Learn More
Upsher-Smith Laboratories, LLC
Careers
News
800-654-2299
Home
Capabilities
Products
Products A-Z
Our Brands
Product Patents
Corporate Development
Corporate Development
New Jersey Office
NASPA Innovation Map
Upcoming Events
Corporate Development Team
About Us
About Upsher-Smith
History
Awards
Community Involvement
Corporate Sponsorships
Charitable Contributions
Policies
Executive Team
News
Careers
Contact Us
Contact Upsher-Smith
Locations
800-654-2299
Capabilities
Products
Products A-Z
Our Brands
Product Patents
Corporate Development
Corporate Development
New Jersey Office
NASPA Innovation Map
Upcoming Events
Corporate Development Team
About Us
About Upsher-Smith
History
Awards
Community Involvement
Corporate Sponsorships
Charitable Contributions
Policies
Executive Team
Contact Us
Contact Upsher-Smith
Locations
Summary of Financial Results for Fiscal Year Ended March 31, 2021
May 13, 2021
Company News
Share:
Share on Facebook
Share on Twitter
Share on LinkedIn
Share via Email
Press Release
Sawai Receives Approvals for Eight Generic Drugs with 20 Strengths
FY2020 Financial Results for fiscal year ended March 31, 2021